PCV6 LONG-TERM COST-EFFECTIVENESS OF EARLY AND SUSTAINED DUAL ORAL ANTIPLATELET THERAPY WITH CLOPIDOGREL FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (CREDO TRIAL)- A FOUR-EUROPEAN COUNTRY ANALYSIS
May 1, 2005, 00:00
10.1016/S1098-3015(10)62647-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)62647-2/fulltext
Title :
PCV6 LONG-TERM COST-EFFECTIVENESS OF EARLY AND SUSTAINED DUAL ORAL ANTIPLATELET THERAPY WITH CLOPIDOGREL FOLLOWING PERCUTANEOUS CORONARY INTERVENTION (CREDO TRIAL)- A FOUR-EUROPEAN COUNTRY ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62647-2&doi=10.1016/S1098-3015(10)62647-2
First page :
Section Title :
Open access? :
No
Section Order :
84